Review: taking Cephalexin and Mirtazapine together


Summary

Drug interactions are reported among people who take Cephalexin and Mirtazapine together. This review analyzes the effectiveness and drug interactions between Cephalexin and Mirtazapine. It is created by eHealthMe based on reports of 317 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Cephalexin and Mirtazapine >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Cephalexin

Cephalexin has active ingredients of cephalexin. It is often used in infection. (latest outcomes from Cephalexin 7,941 users)

Mirtazapine

Mirtazapine has active ingredients of mirtazapine. It is often used in depression. (latest outcomes from Mirtazapine 17,243 users)

On Jul, 17, 2016

317 people who take Cephalexin, Mirtazapine are studied.


Number of reports submitted per year:

Cephalexin and Mirtazapine drug interactions.

Drug effectiveness over time:

Cephalexin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Mirtazapine:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Cephalexin:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 1 people)
Mirtazapine:
  • female: 0.0% - (0 of 1 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Cephalexin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 100.0% - (1 of 1 people)
Mirtazapine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • confusional state
  • hyponatraemia
  • spinal compression fracture
  • pneumonia
  • acute myocardial infarction
  • affective disorder
  • asthenia
  • bladder neck obstruction
  • depressed level of consciousness
  • hydronephrosis
1 - 6 months:
  • colitis ischaemic
  • fatigue
6 - 12 months:
  • affective disorder
  • asthenia
  • depressed level of consciousness
  • inappropriate antidiuretic hormone secretion
  • spinal compression fracture
  • hyponatraemia
1 - 2 years:
  • fatigue
2 - 5 years:
  • calculus urethral
  • depressed level of consciousness
  • flank pain
  • inappropriate antidiuretic hormone secretion
  • obstruction gastric
  • pain
  • pancreatitis
  • pancreatitis acute
  • type 2 diabetes mellitus
  • urethral stenosis
not specified:
  • anxiety
  • pain
  • dyspnoea
  • injury
  • depression
  • arthralgia
  • back pain
  • anaemia
  • osteoarthritis
  • oedema peripheral

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • injury
  • back pain
  • osteoarthritis
  • arthralgia
  • hypoaesthesia
  • osteonecrosis of jaw
  • emotional distress
  • dyspnoea
male:
  • anxiety
  • depression
  • dyspnoea
  • pain
  • drug withdrawal syndrome
  • pain in extremity
  • weight decreased
  • somnolence
  • arthralgia
  • drug dependence

Most common drug interactions by age *:

10-19:
  • hypersensitivity
  • pruritus
  • pyrexia
  • rash
  • rash erythematous
  • suicide attempt
  • urticaria
20-29:
  • affective disorder
  • anxiety
  • paranoia
  • type 2 diabetes mellitus
  • hallucination, visual
  • transaminases increased
  • overdose
  • pancreatitis
  • alcohol use
  • drug abuser
30-39:
  • abdominal pain
  • cellulitis
  • hidradenitis
  • nausea
  • constipation
  • drug dependence
  • drug withdrawal syndrome
  • insomnia
  • depression
  • dysarthria
40-49:
  • depression
  • fatigue
  • dyspnoea
  • pain
  • drug ineffective
  • asthenia
  • confusional state
  • fall
  • headache
  • pain in extremity
50-59:
  • anxiety
  • pain
  • pyrexia
  • injury
  • oedema peripheral
  • bone disorder
  • osteonecrosis of jaw
  • back pain
  • arthralgia
  • osteoarthritis
60+:
  • pain
  • confusional state
  • anxiety
  • weight decreased
  • dyspnoea
  • arteriosclerosis
  • dizziness
  • injury
  • spinal osteoarthritis
  • suicidal ideation

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Cephalexin and Mirtazapine?

Can you answer these questions?

More questions for: Cephalexin, Mirtazapine

You may be interested in these reviews

More reviews for: Cephalexin, Mirtazapine

On eHealthMe, Cephalexin (cephalexin) is often used to treat infection. Mirtazapine (mirtazapine) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.